Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 176224

AbstractMaterial and MethodsResultsDiscussionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2011 | Month : August | Volume : 5 | Issue : 4 | Page : 725 - 728 Full Version

Prevalence and Risk Factors of Hepatitis C among Maintenance Hemodialysis Patients at a Tertiary-Care Hospital in Coimbatore, India


Published: August 1, 2011 | DOI: https://doi.org/10.7860/JCDR/2011/.1476
Surendra Kumar P., Venu G., Madhusudhana Rao A., Balakrishnan N., Saravanan T., Sofia Rani A., Subba Rao T.M.

Department of Nephrology, Biochemistry & Clinical Pathology PSG Institute of Medical Sciences and Research (PSGIMS&R) Coimbatore - 614004 Tamilnadu, India.

Correspondence Address :
Dr. P. Surendra Kumar
Department of Nephrology
PSGIMSR, Coimbatore - 641004.
Tamilnadu, India.
Email: drpsurendra@gmail.com

Abstract

ABSTRACT Background: Haemodialysis (HD) patients are at an increased risk of Hepatitis C virus (HCV) infection, which is significantly associated with increased morbidity and mortality. This study was conducted to determine the prevalence of HCV infection among patients who were put on maintenance HD and its associated risk factors.

Methods: A total of 145 patients (102 males and 43 females) were included in the study. The medical records were reviewed for details regarding history, age, sex, duration of dialysis, dialyzer reuse, blood transfusions, number of dialysis centers and other biochemical data.

Results: Out of 145 patients 18 (12.4%) patients were found to be anti-HCV positive. The mean age of the HCV positive patients was 45.8 ± 13.9 years. There were 13 (72.2%) males in the HCVpositive group and 89 (70.1%) males in the HCV negative group. The mean duration of the dialysis among HCV positive group was 36.6 ± 31.6 months, while it was 18.5 ± 21.2 months for HCV negative ones. The duration of dialysis was significantly longer in HCV positive patients (p = 0.002). Similarly, patients who had dialysis at more than one centre had a higher (55.56%) positivity, which was statistically significant (p = 0.001). Binary logistic regression analysis showed that the duration of dialysis and dialysis at more than one centre were the significant variables for increased positivity.

Conclusion: The patients on HD had 12.4% positivity for anti- HCV in our dialysis unit. Further, the present study demonstrated that the duration of haemodialysis and getting the dialysis done at more than one centre were the important risk factors for acquiring HCV infection in these patients.

Keywords

Maintenance haemodialysis; Hepatitis C; Duration of dialysis, Anti-HCV

Hepatitis C virus (HCV) infection is prevalent among patients who undergo maintenance haemodialysis (HD) and is a particular concern because of the high risk for chronic liver disease, complications in renal transplantation and death in these patients (1). The prevalence of this infection is known to vary widely in different regions of the world. In India, a very wide range of prevalence rates for HCV (4.3- 45.2%) in the HD population have been reported (2)(3)(4)(5)(6)(7).

A number of risk factors have been identified for HCV infection among the dialysis patients, which include cross infections from the sharing of dialysis machines and the dialysis equipment, the reprocessing of dialyzers and blood lines and the increased requirement of blood transfusions [8, 9]. Among this, dialytic age has been considered as a powerful predictor for the risk of the acquisition of the HCV infection. A significant association between the dialytic age and anti-HCV positivity has been reported in several studies (10) (11).Similarly, it has been suggested that the HCV infection occurs among HD patients during repeated dialysis, but not through the equipment (12). However, the situation differs in the developed countries, regarding the prevalence of HCV infection in dialysis patients. The disease in such countries is less prevalent due to many factors including socioeconomic factors, better infection control measures, the use of erythropoietin instead of blood transfusion to treat anaemia and the lower prevalence of the HCV infection among the general population (13).

As far as the literature conveys, the prevalence of HCV infection among the HD patients varies between countries and between the dialysis units within a single country. So far, studies have reported the prevalence of HCV infection in these patients in different regions including the central, western and the northern parts of the country. However, data from the southern part of India on the prevalence of HCV among the HD patients are scanty (6) (7).Hence, the present study was undertaken to assess the occurrence of the HCV infection in patients on maintenance HD. Furthermore, we also evaluated the risk factors which could facilitate the development of an effective strategy to minimize HCV spread among these vulnerable patients.

Material and Methods

Patients: A total of 145 patients who were on maintenance HD for more than three months were included in the study. Of the 145 patients 102 were males and 43 were females, with a median age of 45 years and an age range of 24-72 years. The medical records were examined for details regarding the duration of HD, the frequency of dialysis, blood transfusions in the past one year, the number of dialysis centres which were visited and the reuse of the dialyzer. The causes of renal failure were diabetes, hypertension, chronic glomerulonephritis and other diseases. Patients with acute renal failure who underwent dialysis were excluded from the study. The Institutional Human Ethics Committee approved the study protocol and written informed consent was obtained from all the patients.

Haemodialysis Unit: The HD unit had two routine HD unit areas and one isolated area each for HCV positive and HBV positive patients. The routine HD area had eight machines in each area, the HCV positive area had three machines and the HBV positive area had two machines. All the patients underwent serological testing for HCV, HBV and HIV before initiating the dialysis. Patients who were negative for HCV before initiating the dialysis were dialyzed by using the routine dialysis machines and those who were HCV positive were dialyzed on dedicated machines in the isolated areas. Patients who were seroconverted during the haemodialysis treatment were shifted to the respective isolated area. None of the staff members in the dialysis unit had a history of blood transfusion, drug abuse, or a history of hepatitis B or C infection.

All the patients were essentially treated with three sessions of routine conventional bicarbonate HD each week (3 to 4 h/session) by using standard polysulfone (PS) membranes (Fresenius F-6, 40 mm thick of 1.32 m2 surface area). A dialysate with a standard composition, with bicarbonate buffer was used in all the patients. The blood flow rate was 200 mL/min and the dialysate flow rate was 500 mL/min. The dose of the dialysis was individually adjusted to maintain a Kt/V which was >1.2. All the HD machines were chemically disinfected between each dialysis session. The dialyzers were reused in all the patients.

Specimen collection and Laboratory data: The samples of blood were collected from the patients by using vacutainers (BD, USA), they were centrifuged for 15 min at 2000 rpm and the serum was separated and stored at –200C until analysis. The data regarding the liver function tests were recorded from the patients’ dialysis records and the data was maintained anonymously. The anti- HCV assay was performed by a enhanced chemiluminescence immunoassay (Ortho/ECi), by using the vitros reagent pack and the immunodiagnostic calibrator on the vitros ECi immunodiagnostic system. The Ortho/ECi anti-HCV assay is a two-step sandwich chemiluminescence assay for the qualitative detection of human antibodies in serum or plasma to various proteins of HCV, with a total incubation time of 45 min. The Ortho/ECi system uses a small sample volume (20 μl) for each determination. The results were calculated as a normalized signal relative to the cutoff value (signal/ cutoff [S/C] ratio). The patient samples with a single S/C ratio of ≥1.00 were considered to be test positive. If the S/C ratio was <0.90, the sample was considered as negative. Samples with an S/C ratio of ≥0.90 and <1.00 were retested in duplicate, based on the manufacturer’s recommendations.

Statistical Analysis
The data analysis was performed by determining the frequencies and the percentages for the variables under study. The unpaired Students “t” test was used to compare the quantitative parameters between the anti-HCV negative and the anti-HCV positive group. The Chi-square test was used for the categorical data. A ‘p’ value which was <0.05 was considered to be statistically significant. Logistic regression analysis was done to determine the risk factors by taking anti HCV as a dependent variable. The statistical analysis was performed by using the statistical software, SPSS version 16.0.

Results

The patients included in this study were divided into two groups, anti-HCV positive and anti-HCV negative. The demographic and the clinical characteristics of these patients are shown in (Table/Fig 1). Among the 145 patients on HD, 18 patients (12.4%) were found to be anti-HCV positive. There were 13 (72.2%) males in the HCVpositive group and 89 (70.1%) males in the HCV negative group. Anti-HCV antibodies were present prior to the dialysis in only eight of the patients who were included in the study population. Ten (10) of them acquired the antibodies during the course of the study. The anti-HCV positivity was 8.6% in patients who underwent dialysis at one centre, whereas the patients who had dialysis at more than one centre had a higher positivity (56%).

A comparison between the two groups, the anti-HCV positive and the anti-HCV negative groups, is shown in (Table/Fig 2). The mean duration of the dialysis among the HCV positive patients was 36.67 ± 31.68 months, while in the HCV negative patients, it was 18.50 ± 21.29 months, which was statistically significant (p = 0.002). Similarly, patients who had the dialysis at more than one centre had a higher (55.56%) positivity, which was statistically significant (p = 0.001). The proportion of surgeries was higher in the anti-HCV positive group (100.0%) as compared to that in the negative group (90.55%), (p = 0.017). There was no statistically significant difference between the two groups with regards to other risk factors (ALT, AST, ALP and blood transfusion which were received in one year).

Logistic Regression analysis was done by taking anti-HCV positivity as a dependant variable and other suspected variables (diabetes, haemodialysis duration, dialysis at more than one centre and blood transfusions) as independent variables or risk factors (Table/Fig 3). For the analysis, 145 patients were considered, as these patients contained the values of these independent variables. The duration of dialysis (p = 0.034) and the dialysis at more than one centre (p = 019) were found to be statistically significant. The basic disease diagnosis (diabetic or nondiabetic) and the blood transfusions were found to be statistically insignificant.

Discussion

It is well known that HD patients are at a high risk for the development of HCV infection. The prevalence of the HCV infection varies widely from 8% to 45% in these patients (2)(3)(4)(5)(6)(7). Reddy et al (2005) reported 13.3% (7), Chandra et al (2004) reported 43% (6), Agarwal et al (1999) reported 42% (3), and recently, Jasuja et al (2009) reported 27.7 % (2). The highest reported incidence from a single HD unit was 43% (6). The reason for this variation in the prevalence rates of HCV among the HD patients which were reported from different parts is unknown. However, Reddy et al(2005) reported that stringent blood testing and the isolation of the dialysis machines have helped in the reduction of the transmission of hepatitis C among HD patients and that this was the reason for the low prevalence of HCV (7). In the present study, we found a low anti-HCV prevalence among the maintenance HD patients at our dialysis centre (12.4% and 72.2% in males and 27.8% in females), which was in harmony with the results of the study which was done by Reddy et al (2005) (13.3%) (7). Strict adherence to infection control measures in the dialysis setting, the use of dedicated machines, equipments and isolated areas and separate washing areas for the positive patients may be the reason for the low prevalence (12.4%) in our dialysis unit. Similarly, we found a low sero-conversion rate (7.44%) at our dialysis centre. Only 10 of the included patients became seropositive after the initiation of haemodialysis. However, the acquisition of the infection by some individuals after the initiation of dialysis was possibly because of the breach in the infection control strategies during the dialysis.

Many factors may have contributed to the prevalence of the positive anti-HCV in the HD patients. Some of these have been confirmed in the present study. Of the risk factors for the HCV transmission during HD, blood transfusion was an important factor. Several studies (14)(15)(16) showed that the risk of acquiring the HCV infection increased with an increase in the number of units of blood which were transfused. However, in the present study, we found nosignificant association between the blood transfusions and the anti- HCV positivity. Few other investigators (2), (17) have also forwarded similar results and have suggested that an association between dialysis-associated hepatitis and transfusion does not imply a causal relationship, but that rather it is related to the duration of the dialysis.

Most studies concur that the duration of dialysis is closely related to a positive anti-HCV rate (2), (15), (18). The prevalence of HCV infection in the HD patients in our setup was low (12.4%). However, its association with the duration of dialysis was found to be statistically significant. Our results also emphasized that the longer dialysis duration was a significant risk factor for acquiring HCV infection. Interestingly, in the present study, we found a significant association between the anti-HCV positivity and patients who had dialysis at more than one centre, which was a new finding of the study. Furthermore, there are few studies (19), (20) which have reported a higher incidence of HCV infection in the presence of reuse of the dialyzer. In our study, there was no significant impact of the dialyzer reuse.

As per the literature review, anti-HCV positive patients had significantly elevated levels of liver enzymes than the HCV negative patients (15), (21), (22). In a recent study, Jasuja et.al (2) (2009) reported a significant correlation of HCV RNA positivity with elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Moreover, the study found that ALT was a significant risk factor for HCV RNA positivity. However, in the present study, the values of ALT and AST were similar in both the groups. Transaminase levels are rarely used for the detection of liver disease in these patients, because they are usually low even in patients with a normal hepatic function and histology, who are on dialysis. Hence, the presence of similar values in positive and negative patients in this study should not be considered as being unusual.

The main limitation of the present study was the inability to adopt HCV RNA PCR as a screening test due to the high costs. We used enhanced chemiluminescence immunoassay as a screening test for the HCV infection. This was more sensitive and specific than the third generation ELISA and we used strong cutoff points to detect the HCV positivity (23).

In conclusion, although the prevalence of the HCV infection among patients on HD at our dialysis centre was lower than that in other parts of the country, it still remains high. We believe that preventive measures and the adherence to ‘universal precautions for HCV control’ remain a priority. Hence, we recommend the use of dedicated dialysis equipment, spaces, nursing staff, separate washing areas and the screening of the patients once in 3 months, for preventing cross-infection. Furthermore, the present study demonstrated that along with the duration of HD, dialysis at more than one centre was also an important risk-factor for acquiring the HCV infection.

References

1.
Petrosillo N, Gilli P, Serraino D, Dentico P, Mele A, Ragni P. et.al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001; 37:1004-1010.
2.
Jasuja S, Gupta AK, Choudhary R, Kher V, Agarwal DK, Misra A. et.al. Prevalence and association of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. Indian J Nephrol 2009; 19: 62-68.
3.
Agarwal SK, Dash SC, Irshad MC. Hepatitis C virus infection during hemodialysis in India. J Assoc Physicians India 1999; 47:1139-43.
4.
Jaiswal S, Chitnis D, Salgia P, Sepaha A, Pandit C. Prevalence of the hepatitis virus among chronic renal failure patients on hemodialysis in central India. Dialysis Transplant 2002; 31: 234-38.
5.
Saha D, Agarwal SK. Hepatitis and HIV infection in hemodialysis patients. J Indian Med Assoc 2001; 99: 194-9,203,213.
6.
Chandra M, Khaja MN, Hussain MM, Poduri CD, Farees N, Habeeb MA, et.al. Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology 2004; 47: 374-376.
7.
Reddy GA, Dakishnamurthy KV, Neelaprasad P, Gangadhar T, Lakshmi V. Prevalence of HBV and HCV dual infection in patients on hemodialysis. Indian J Med Microbiol 2005; 23: 41-43.
8.
Salama G, Rostaing L, Sandres K, Izopet J. Hepatitis C infection in a French hemodialysis unit; a multicenter study. J Med Virol 2000; 61: 44-51.
9.
Jaiswal SP, Chitnis DS, Naik G, Artwani KK, Pandit CS, Salgia et al. Prevalence of anti-HCV antibodies in central India. Indian J Med Res 1996; 104:177-81.
10.
Hardy NM, Sandroni S, Danielson S, Wilsom WJ. The antibody to the Hepatitis C Virus increases with time on hemodialysis. Clin Nephrol 1992; 38:44-48.
11.
Niu MT, Coleman PJ, Alter MJ. A multicenter study on the hepatitis C virus infection in chronic hemodialysis patients and hemodialysis staff members. Am J Kidney Dis 1993; 22:568-573.
12.
Okuda K, Hayashi H, Kobayashi S, Irie Y. The mode of the hepatitis C infection is not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995; 23:28-31.
13.
Kalantar-Zadeh K, McAllister CJ, Miller LG. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study. Nephrol Dial Transplant 2005; 20: 1662-1669.
14.
Saab S, Martion P, Brezina M, Gitrich G, Yee HF Jr. Serum alanine aminotransferase in hepatitis C screening of the patients on hemodialysis. Am J Kidney Dis 2001; 37: 308-15.
15.
Dentico P, Buogiorno R; Volpe A. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors. Clin Nephrol 1992; 38:49-52.
16.
Alfurayh O, Sobh M, Buali A, Ali MA, Barri Y, Qunibi W, et al. Hepatitis C virus infection in chronic hemodialysis patients: A Clinicopathological study. Nephrol Dialysis Transplant 1992; 7:327-332.
17.
Hardy NM, Sandroni S, Danielson S, Wilson WJ. The antibody to the hepatitis C virus increases with time on hemodialysis. Clin Nephrol 1992; 38: 44-48.
18.
Donahue JG, Munoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, et.al. The declining risk of the post transfusion hepatitis C virus infection. N Engl J Med 1992; 327:369-73.
19.
dos Santos JP, Loureiro A, Cendoroglo Neto M, Pereira BJ. The impact of the dialysis room and reuse strategies on the incidence of the hepatitis C infection in hemodialysis units. Nephrol Dial Transplant 1996; 11:2017-22.
20.
Jadoul M, Cornu C, van Ypersele de Strihou C. Incidence and risk factors for hepatitis C seroconversions hemodialysis: A Prospective study. Kidney Int 1993; 44:1322-6.
21.
Natov SN, Lau JY, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, et al. Serological and virological profiles of the hepatitis C infection in renal transplant candidates. Am J Kidney Dis 1998; 31: 920-927.
22.
Herrine SK, Michael B, Na WL, Rossi S, Dunn SR, Hyslop T. Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis. Am J Gastroenterol 2002; 97: 2619-22.
23.
Sherman KE, Rouster SD, Horn PS. Comparison of the Methodologies for the Quantification of the Hepatitis C Virus (HCV) RNA in Patients who are Co infected with the HCV and the Human Immunodeficiency Viruses. Clin Infect Dis 2002; 35:482-7.

DOI and Others

JCDR/2011/1476

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com